Pharmacology Biochemistry And Behavior

Journal Title：Pharmacology Biochemistry And Behavior

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.

《藥理學生物化學與行為》發表藥理學和生物化學領域的原創報告，主要側重點和理論背景是行為。投稿可能涉及臨床、臨床前或基礎研究。純生物化學或毒理學研究將不予發表。描述新型藥物在精神、神經和認知障礙以及中樞疼痛模型中的行為影響的論文必須包括陽性對照，除非該論文研究的疾病尚無此類藥物。我們不接受關注生理過程（例如外周疼痛機制、體溫調節、癲癇發作）的論文，因為我們希望將《藥理學生物化學與行為》的重點放在行為及其與中樞神經系統的生物化學和神經化學的相互作用上。描述植物材料影響的論文通常不予考慮，除非研究了活性成分、很好地描述了提取方法、已知測試劑量并提供了關于活性成分作用機制的明確實驗證據。

Pharmacology Biochemistry And Behavior創刊于1973年，由Elsevier Inc.出版商出版，收稿方向涵蓋醫學 - 行為科學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 一般,3-6周 ，影響因子指數3.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。